70 related articles for article (PubMed ID: 961180)
21. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome.
Shapiro DL; Notter RH; Morin FC; Deluga KS; Golub LM; Sinkin RA; Weiss KI; Cox C
Pediatrics; 1985 Oct; 76(4):593-9. PubMed ID: 3900907
[TBL] [Abstract][Full Text] [Related]
22. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
Kinalski M; Sledziewski A; Kretowski A
Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922
[TBL] [Abstract][Full Text] [Related]
23. [Prenatal steroids for fetal maturation in preterm birth. Experience at an institution].
Arroyo Cabrales LM; Guzmán Bárcenas J
Ginecol Obstet Mex; 2000 Nov; 68():448-52. PubMed ID: 11195957
[TBL] [Abstract][Full Text] [Related]
24. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes.
Peaceman AM; Bajaj K; Kumar P; Grobman WA
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1165-9. PubMed ID: 16157131
[TBL] [Abstract][Full Text] [Related]
25. Incidence of respiratory distress syndrome following antenatal betamethasone: role of sex, type of delivery, and prolonged rupture of membranes.
Papageorgiou AN; Colle E; Farri-Kostopoulos E; Gelfand MM
Pediatrics; 1981 May; 67(5):614-7. PubMed ID: 7254990
[TBL] [Abstract][Full Text] [Related]
26. Perinatal intervention and neonatal outcomes near the limit of viability.
Louis JM; Ehrenberg HM; Collin MF; Mercer BM
Am J Obstet Gynecol; 2004 Oct; 191(4):1398-402. PubMed ID: 15507972
[TBL] [Abstract][Full Text] [Related]
27. [Induction of fetal lung maturation in the prevention of hyaline membrane disease: the connection with neonatal sepsis].
Driul L; Furlan R; Macagno F; Pezzani I; Plaino L; Ianni A; Casarsa S; Zavarise D; Marchesoni D
Minerva Ginecol; 2003 Feb; 55(1):37-42. PubMed ID: 12598841
[TBL] [Abstract][Full Text] [Related]
28. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
[TBL] [Abstract][Full Text] [Related]
29. [Obstetric and neonatological aspects relating to incidence and importance of respiratory distress syndrome in prematurely born infants (author's transl)].
Müller K; Tiller R
Zentralbl Gynakol; 1981; 103(18):1070-80. PubMed ID: 7315007
[TBL] [Abstract][Full Text] [Related]
30. Prolonged fetal ritodrine exposure and immediate neonatal outcome.
Musci MN; Abbasi S; Otis C; Bolognese RJ
J Perinatol; 1988; 8(1):27-32. PubMed ID: 3236090
[TBL] [Abstract][Full Text] [Related]
31. [Prevention of the neonatal lung immaturity].
Zhekova N; Mikhova M; Nikolov A; Dimitrov A
Akush Ginekol (Sofiia); 2009; 48(1):11-5. PubMed ID: 19496457
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone for prevention of respiratory distress syndrome: multiple perinatal factors.
Caspi E; Schreyer P; Weinraub Z; Lifshitz Y; Goldberg M
Obstet Gynecol; 1981 Jan; 57(1):41-7. PubMed ID: 6893857
[TBL] [Abstract][Full Text] [Related]
33. Corticosteroid treatment for prevention of prematurity complications.
Celik C; Acar A; Cicek N; Koc H; Ak D; Akyurek C
Arch Gynecol Obstet; 2002 Dec; 267(2):90-4. PubMed ID: 12439554
[TBL] [Abstract][Full Text] [Related]
34. Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy.
McEvoy C; Schilling D; Spitale P; Peters D; O'Malley J; Durand M
Pediatrics; 2008 May; 121(5):e1032-8. PubMed ID: 18450845
[TBL] [Abstract][Full Text] [Related]
35. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study.
Ring AM; Garland JS; Stafeil BR; Carr MH; Peckman GS; Pircon RA
Am J Obstet Gynecol; 2007 May; 196(5):457.e1-6. PubMed ID: 17466700
[TBL] [Abstract][Full Text] [Related]
36. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial.
Enhorning G; Shennan A; Possmayer F; Dunn M; Chen CP; Milligan J
Pediatrics; 1985 Aug; 76(2):145-53. PubMed ID: 3895150
[TBL] [Abstract][Full Text] [Related]
37. Antenatal prevention of respiratory distress syndrome; a multicentre survey.
Luerti M; Bevilacqua G; Volante E; Angiolillo M; Tomassini A; Gaioni L; Ziino L; Vignali M; Conti M
Eur Respir J Suppl; 1989 Mar; 3():53s-56s. PubMed ID: 2662996
[TBL] [Abstract][Full Text] [Related]
38. Normal physical and mental development of 6-year-old children whose mothers were treated antenatally with prednisolone.
Horváth I; Adamovich K; Arató J; Ostorharics-Horváth G; Papp K
Acta Paediatr Hung; 1984; 25(4):395-8. PubMed ID: 6549260
[TBL] [Abstract][Full Text] [Related]
39. [Prevention and therapy of the respiratory distress syndrome in premature infants using lecithin. Distribution of 14C--labeled lecithin after intravenous and intraamnial administration in pregnant miniature pigs?].
von Klitzing L; Endell W; Grosspietzsch R; Klink F; Oberheuser F
Fortschr Med; 1977 Feb; 95(8):501-4. PubMed ID: 856706
[TBL] [Abstract][Full Text] [Related]
40. Intraamniotic surfactant for prevention of neonatal respiratory distress syndrome (IRDS): rationale and personal experience.
Cosmi EV; La Torre R; Piazze JJ; Maranghi GL; Lerro N; Bianco D; Anceschi MM
Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):135-9. PubMed ID: 9138955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
